The study’s results indicated that DHA supplementation significantly lowered TNF-α and IL-6 levels, concurrently boosting glutathione peroxidase activity and heme oxygenase-1 mRNA expression in macrophages of AAA patients. The gene discussed is IL6; the disease is triple-A syndrome.